Q3 2022 Dr Martens PLC Trading Statement Call Transcript
Good morning, and welcome to Dr. Martens FY 2023 Q3 trading update. My name is Harry, and I'll be coordinating your call today. (Operator Instructions)
I would now like to hand you over to Kenny Wilson, CEO, to begin. Kenny, please go ahead.
Thank you very much. Good morning, everyone. And firstly, a big thank you for joining our Q3 results call at such short notice.
We've obviously accelerated this call due to a significant reduction to our FY 2023 forecast. This is something that I'm extremely disappointed about. This disappointment is even greater because a large part of our miss should have been within our control, and it is a people and process failure.
Due to a large operational challenge in our new Los Angeles distribution center and weaker-than-expected DTC trading in the United States, we now expect full-year revenue growth of 11% to 13% on an actual currency basis and full-year EBITDA between GBP250 million and GBP260 million. We are also reducing guidance for FY 2024, which Jon will
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |